Back
to sessions
Sep 29
Poster Q & A
PQA 04 - Gynecological Cancer, Head and Neck Cancer
session DESCRIPTION
ASTRO's posters feature the latest scientific case studies, practice innovations and research from experts in the field of radiation oncology, including Clinical Trials in Progress.
Poster presentations will be accessible to both live and virtual meeting attendees starting at 5:00 p.m. Eastern time, on Friday, September 26, 2025. Posters can be viewed through the Annual Meeting portal and in the Virtual Poster Library.
During scheduled times, attendees will have the opportunity to ask poster presenters questions about their research. Posters will be organized by track.
Presentations
-
10:45am - 12:00pm PT
A Deep-Learning Model Integrating Multi-Modality Data for Predicting the Recurrence of Nasopharyngeal Carcinoma
Speaker: Yuting Wang, MD - Sun Yat-Sen University Cancer Center, Guang Dong Province -
10:45am - 12:00pm PT
A Double-Blinded Analysis of Anterior Oral Mucositis in Patients with Advanced Oropharyngeal Cancer Treated with IMPT vs. IMRT
Speaker: Steven Frank, MD, FASTRO - MD Anderson Cancer Center, Houston -
10:45am - 12:00pm PT
A Generalizable Foundation Model for Deep Learning-Based Automated CT Lymph Node Delineation
Speaker: Wenjun Liao, PhD - Sichuan Cancer Hospital & Institute, Cancer Hospital affiliate to School of Medicine, University of Electronic Science and Technology of China, Chengdu -
10:45am - 12:00pm PT
A Local-Global Integration Network for Enhancing CBCT Quality in Cervical Cancer Radiotherapy
Speaker: Hua Yang, MD - The First Affiliated Hospital of Air Force Medical University, Xi’an -
10:45am - 12:00pm PT
A Multicenter Study Comparing Survival Outcomes of IMRT and Non-IMRT Techniques in Non-Metastatic Nasopharyngeal Cancer Using Propensity Score Matching
Speaker: Chuleeporn Jiarpinitnun, MD - Faculty of Medicine Ramathibodi Hospital, Ratchataewi -
10:45am - 12:00pm PT
A Multi-Omics Model Predicting Acute Hematologic Toxicity (HT) in Locally Advanced Cervical Cancer Undergoing External-Beam Radiotherapy
Speaker: Xin Yang, PhD - State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University, Guangzhou -
10:45am - 12:00pm PT
A Novel Combination of Carbon Ion Radiotherapy with Image-Guided Brachytherapy for Locally Advanced Cervical Adenocarcinoma
Speaker: Takuya Kumazawa, MD, PhD - Gunma University, Maebashi -
10:45am - 12:00pm PT
A Novel Stratification Score for Oral Cavity Carcinoma Prediction of Locoregional Failure and Overall Survival
Speaker: Zain Husain, MD - Southern California Permanente Medical Group, Ontario -
10:45am - 12:00pm PT
-
10:45am - 12:00pm PT
A Prospective Study Comparing Acute Toxicities in FIGO Stage IIIC1r Carcinoma Cervix Patients Receiving Semi-Extended Field Radiotherapy vs. Previously Treated Patients of Whole Pelvis Radiotherapy
Speaker: Sobhana Vallabhaneni, - Max Superspeciality Hospital, Saket, New Delhi -
10:45am - 12:00pm PT
A Randomized, Controlled, Single-Blind, Multicenter Phase II/III Clinical Trial of PD-1 Inhibitor Combined with Chemoradiotherapy for the Treatment of T1-2N2-3/T3-4N0-3M0 Stage Nasopharyngeal Carcinoma — Study Protocol
Speaker: Hongyuan Jia, RT - Sichuan Cancer Hospital and Institute, Chengdu -
10:45am - 12:00pm PT
A Randomized, Prospective Trial of Hydrogen-Rich Water (HRW) to Mitigate Acute Mucositis during Radiation Therapy
Speaker: Kartik Mani, MD, PhD - Stony Brook University Hospital, Stony Brook -
10:45am - 12:00pm PT
A Randomized, Single-Center, Phase II Trial of Endoscopic NBI Combined with MRI to Guide the Individualized Clinical Target Volume Delineation in Eccentric Nasopharyngeal Carcinoma
Speaker: Yuwei Wang, MD - Chongqing University Cancer Hospital, Chongqing -
10:45am - 12:00pm PT
-
10:45am - 12:00pm PT
Adaptive Radiotherapy in Head and Neck Cancers - When do We Replan?
Speaker: Sanjay Hunugundmath, MD - Sahyadri Hospital, Pune -
10:45am - 12:00pm PT
Addressing the Need for 3D Tumor Margin Localization in Radiation Oncology
Speaker: Mark Schuweiler, MSE - Johns Hopkins University, Baltimore -
10:45am - 12:00pm PT
Analysis of Disparities in Prolonged Radiation Course in Definitive Cervical Cancer Treatment
Speaker: Sabrina Mellinghoff, M2 - Boston University School of Medicine, Boston -
10:45am - 12:00pm PT
-
10:45am - 12:00pm PT
Artificial Intelligence-Aided Investigation of the Association of Bone Marrow Dosimetric Parameters with Hematological Toxicity in Cervical Cancer Patients Undergoing Radiochemotherapy
Speaker: Shuang Zhao, MD - Cancer Hospital of Chinese Academy of Medical Sciences Hospital, BEIJING -
10:45am - 12:00pm PT
-
10:45am - 12:00pm PT
Assessing the Dosimetric Impact of Bolus Positioning Variability in Vulvar Cancer Radiotherapy
Speaker: Mohammed Qamber, MD - Bahrain Oncology Center, Muharraq -
10:45am - 12:00pm PT
Assessing the Safety of Delayed Elective Nodal Irradiation through Pre-Treatment Nodal Kinetics in High-Risk OPSCC
Speaker: George Li, MD - University of Toronto, Toronto -
10:45am - 12:00pm PT
Association of Systemic Inflammation Response Index with Outcomes among Patients with Head and Neck Cancer Receiving Definitive Chemoradiation
Speaker: Neil Almeida, MD - Roswell Park Comprehensive Cancer Center, Buffalo -
10:45am - 12:00pm PT
Association of Systemic Inflammation Response Index with Outcomes for Head and Neck Cancer
Speaker: Andrew Koempel, BS - The Ohio State University Comprehensive Cancer Center, Columbus -
10:45am - 12:00pm PT
Auto-Contouring and Observer Variations in MR-Guided Brachytherapy for Cervical Cancer
Speaker: Chun Him Frederick Law, MS - Hospital Authority, Hong Kong -
10:45am - 12:00pm PT
Automated vs. Manual Salivary Gland Segmentation for Xerostomia Risk Assessment in Head and Neck Cancer Patients from the ARTSCAN III trial
Speaker: Viktor Rogowski, MS - Skane University Hospital, Lund -
10:45am - 12:00pm PT
Awareness of Carcinogenic Effects of Betel Nut in Oral Cavity Cancer among South Asians in the United States
Speaker: Swati Mamidanna, MD - Rutgers Cancer Institute of New Jersey, New Brunswick -
10:45am - 12:00pm PT
Berberine Mitigates the Hypofunction of Salivary Gland after Radiotherapy Induced Injury
Speaker: Qihang Lian, - Sichuan Cancer Hospital & Institute, Chengdu -
10:45am - 12:00pm PT
Brachytherapy for the Treatment of Ocular Melanoma: Comparing Yttrium-90 (Y90) to Palladium (Pd-103) and Iodine (I-125)
Speaker: Lauren Jacobs, MD - Mount Sinai Hospital, New York -
10:45am - 12:00pm PT
Can Pre-Radiation Therapy MRI Imaging Predict Osteoradionecrosis in Oral Cavity Cancer?
Speaker: Aishwarya Shah, MD - NYU Langone Health, New York -
10:45am - 12:00pm PT
Cardiovascular Events Following Radiotherapy for Oropharyngeal Cancer: Incidence, Risk Factors, and Timing of Events
Speaker: Adam Holtzman, MD - Mayo Clinic Florida, Jacksonville -
10:45am - 12:00pm PT
Cervical Osteomyelitis with Head and Neck Cancer Radiotherapy: Single Institutional Experience
Speaker: Conan Zhao, PhD - Mayo Clinic Alix School of Medicine, Rochester -
10:45am - 12:00pm PT
Chemotherapy plus Nimotuzumab and Immunotherapy as Induction Regime Followed by Sequential Chemoradiotherapy and Consolidation Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Prospective, Single-Arm, Open-Label, Phase II Trial
Speaker: Mai Zhang, MS - department of radiation oncology, XiJing hospital, Xi'an -
10:45am - 12:00pm PT
Clinical and Demographic Characteristics, along with Oncological Outcomes, Following Multimodal Treatment of Sinonasal Carcinoma
Speaker: Anjali R, MD, MBBS - All India Institute of Medical Sciences, New Delhi -
10:45am - 12:00pm PT
Clinical and Histopathological Predictors of Disease-Free Survival in Mucoepidermoid Carcinoma: A Single Institution Retrospective Analysis
Speaker: Petria Thompson, MD, PhD - University of California San Francisco, San Francisco -
10:45am - 12:00pm PT
Combustible Cannabis Use and Treatment Outcomes in Patients with Head and Neck Cancer Treated with Radiation Therapy
Speaker: Ahmed Ghanem, MD, PhD - Henry Ford Cancer Institute/Alexandria University, Detroit -
10:45am - 12:00pm PT
Comparative Analysis of Radiation-Induced Proctitis in Hypofractionated vs. Conventional Pelvic Radiotherapy for Cervical Cancer: Evaluating Incidence, Risk and Mitigation Strategies
Speaker: Abba Mallum, MD, PhD, MBBS - Department of Radiotherapy and Oncology, Inkosi Albert Luthuli Central Hospital, Durban -
10:45am - 12:00pm PT
Comparative Dosimetric Analysis of Adjuvant Post-Op Pelvic IMRT Using Standard Volumes vs. EMBRACE Low-Risk Pelvic Volume for Patients with Stage I Cervical Cancer Meeting Sedlis Criteria
Speaker: Carolina Padilla, MD - Prime West Consortium Desert Valley Hospital, Hallandale Beach -
10:45am - 12:00pm PT
Conditional Survival and Dynamic Failure Hazard of Oral Cavity Squamous Cell Carcinoma: Shedding Light on the Optimization of Treatment and Surveillance
Speaker: Nuo Yu, BS - Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing -
10:45am - 12:00pm PT
Cone Beam Computed Tomography (CBCT)-Based Imaging Tracking of Primary Tumor, Lymph Nodes, and Parotid Glands in Nasopharyngeal Carcinoma (NPC) for Tailored Treatment Strategy and Functional Preservation
Speaker: Guan-Qun Zhou, MD, PhD - Sun Yat-Sen University Cancer Center, Guang Dong Province -
10:45am - 12:00pm PT
Correlation of Metabolic Response Assessed by PET-CT Metrics with Survival in Locally Advanced Nasopharyngeal Carcinoma
Speaker: Faisal Alsamari, MBBS - King Faisal Specialist Hospital and Research Centre, Riyadh -
10:45am - 12:00pm PT
Craniocaudal Spread Patterns of Retropharyngeal Lymph Node Metastasis in Patients with Oropharyngeal Carcinoma
Speaker: Mika Nakatake, MD - Nagasaki University, Nagasaki -
10:45am - 12:00pm PT
Decreased Radiation Dose to Oral Tongue with Tongue-Out Radiotherapy Compared to Non Tongue-Out Radiotherapy for Head and Neck Cancer
Speaker: Whoon Jong Kil, MD - UPMC North Central Pa, Williamsport -
10:45am - 12:00pm PT
Deep Learning for Automatic T-Staging Prediction of Laryngeal Cancer Using CT Scan and Radiology Report
Speaker: Dakai Jin, PhD - Alibaba Group (US) Inc., New York -
10:45am - 12:00pm PT
Deep Learning-Based Synthetic CT Generation from MRI for Head and Neck Cancer Radiation Therapy Planning
Speaker: Dionee Liefman, MBBS, FRANZCR, AFRACMA - Queensland Health, Southport -
10:45am - 12:00pm PT
Delta Radiomic Analysis during Radiotherapy Potentially Predicts Oncologic Outcomes in Locally Advanced Vulvar Cancer
Speaker: Abdulla Alzibdeh, MD - King Hussein Cancer Center, Amman -
10:45am - 12:00pm PT
Development and Assessment of Interstitial Brachytherapy Using Individual Curved-Needle in Treatment of Recurrent Gynecological Tumors after External Beam Radiotherapy
Speaker: Zheng Zeng, MD - Peking Union Medical College Hospital, Beijing -
10:45am - 12:00pm PT
-
10:45am - 12:00pm PT
Development of a Validated Radiation Score for Treatment Compliance in Gynecological Cancer Patients Receiving Radiation Therapy
Speaker: Adyasha Pradhan, MS, BS - Northwell Health, Lake Success -
10:45am - 12:00pm PT
Development of an Interpretable Machine Learning-Based Prediction Model for Long-Term Dysphagia Following Intensity-Modulated Radiotherapy in Nasopharyngeal Carcinoma
Speaker: Xuguang Wang, MD - Sun Yat-Sen University Cancer Center, Guang Dong Province -
10:45am - 12:00pm PT
Development of Radiomic Models Incorporating Neural Networks for Early Prognostic Prediction in Patients with Locally Advanced Cervical Cancer
Speaker: Chang Cai, MD, BS - Ruijin Hospital, Shanghai JiaoTong University School of Medicine,, Shanghai -
10:45am - 12:00pm PT
Disparities in the Distances Traveled for Gynecological Radiotherapy in Brazil: A Cross-Sectional Study (2019-2022)
Speaker: Andre Gouveia, MD, MBA - McMaster University, Hamilton -
10:45am - 12:00pm PT
Does Adjuvant Radiation Affect Facial Nerve Recovery? A Hidden Setback Following Total Facial Nerve Sacrifice
Speaker: Austin Williams, BS - Baylor College of Medicine, Houston -
10:45am - 12:00pm PT
Does the Addition of Chemotherapy to Adjuvant Radiation Benefit the Survival for Patients with Adenocarcinoma of Cervix after Radical Surgery? A Single-Center Retrospective Cohort Study
Speaker: Xilin Yang, MD - Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing -
10:45am - 12:00pm PT
Dose-Dependent Occurrence of Nasolacrimal Duct Obstruction and Eye Watering after Radiation Therapy for Nasal/Paranasal Malignant Tumors
Speaker: Hiroki Kawaguchi, MD, PhD - Kobe University Hospital, Kobe City -
10:45am - 12:00pm PT
Dosimetric Benefits of Adaptive Radiotherapy for Nasopharyngeal Carcinoma: A Weekly FBCT-Based Dose Accumulation Study
Speaker: Guan-Qun Zhou, MD, PhD - Sun Yat-Sen University Cancer Center, Guang Dong Province -
10:45am - 12:00pm PT
Dosimetric Evaluation of Urethral Dose and Toxicity in Image-Guided Brachytherapy (IGBT) for Gynecological Cancers: Implications for Organ-at-Risk (OAR) Consideration
Speaker: Ana Paula Galerani, MD, MS - University Medical City, Sultan Qaboos Comprehensive Cancer Care and Research Center, Muscat -
10:45am - 12:00pm PT
-
10:45am - 12:00pm PT
Effect of Adjuvant Treatment Modality on Survival Outcomes by FIGO Grade in Locally Advanced Endometrial Cancer
Speaker: Aranee Sivananthan, MD, MS, BS - University of Chicago, Chicago -
10:45am - 12:00pm PT
Effect of Proton vs. Photon Radiation Therapy on Bone Density and Insufficiency Fractures in Gynecologic Patients
Speaker: Sayeh Fattahi, MD - Harvard Radiation Oncology Program, Boston -
10:45am - 12:00pm PT
Effect of Tumor Volume and Dose on Local and Regional Control in HPV-Related Oropharyngeal Squamous Cell Carcinoma
Speaker: Xuguang Chen, MD, PhD - University of North Carolina, Chapel Hill -
10:45am - 12:00pm PT
Efficacy and Safety of Immunotherapy vs. Cetuximab Concurrent with Radiotherapy in Cisplatin-Ineligible Locally Advanced Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
Speaker: Tin Tun, MD, MBBS - Shasta Regional Medical Center- Prime West Consortium, Redding -
10:45am - 12:00pm PT
Elevated Cerebrovascular Risk in Post-Radiotherapy Head and Neck Cancer Survivors: A Real-World Data Analysis from TriNetX
Speaker: Jeng-You Wu, MD, MBA - Taipei Municipal WanFang Hospital, Taipei -
10:45am - 12:00pm PT
-
10:45am - 12:00pm PT
Evaluating Genomic Changes as Biomarkers of Chemoradiation Therapy Response in Locally Advanced Cervical Cancer
Speaker: Bryan Nolasco, BS - Albert Einstein College of Medicine, Bronx -
10:45am - 12:00pm PT
Evaluating Statistical Cure Probability and Cure Time in Cervical Cancer Patients Based on a Mixture Cure Model
Speaker: Dingchao Liu, MD - Peking Union Medical College Hospital, Beijing -
10:45am - 12:00pm PT
Evaluation of Deep-Learning-Based Commercial Contouring Software for CT-Based Gynecological Brachytherapy
Speaker: Haechan Yang, BMSc - Schulich School of Medicine and Dentistry, London -
10:45am - 12:00pm PT
Evaluation of Efficacy and Safety of Proton Reirradiation in Head and Neck Cancers: Institutional Outcomes and Toxicity Profile Analysis
Speaker: Taylor MacDonald, DO - University of Cincinnati Medical Center/College of Medicine, Cincinnati -
10:45am - 12:00pm PT
Expert-Constrained Deep Learning Framework for Nasopharyngeal Carcinoma Automated Target Delineation
Speaker: Jing Huang, MD, PhD - Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan -
10:45am - 12:00pm PT
Exploiting Semantic Asymmetry to Enhance the Accuracy of Gross Tumor Volume Delineation in Nasopharyngeal Carcinoma on Planning CT
Speaker: Xianghua Ye, MD, PhD - The First Affiliated Hospital of Zhejiang University Medical College, hangzhou -
10:45am - 12:00pm PT
Exploratory Study on the Correlation between Pelvic Bone Marrow Dose-Volume Effects and Changes in Peripheral Blood Lymphocyte Subpopulations after Whole Pelvic Irradiation
Speaker: Yi-Wei Wang, - Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai -
10:45am - 12:00pm PT
Exploring the Use of Advanced DWI Techniques to Improve Prediction of Early Treatment Response during Definitive Chemoradiation for Cervical Cancer
Speaker: Vonetta Williams, MD, PhD - Memorial Sloan Kettering Cancer Center, New York -
10:45am - 12:00pm PT
Extended-Field Chemoradiation in Cervical Cancer with PET/CT-Detected Para-Aortic Lymph Node Metastases
Speaker: Helen Chen, MD, PhD - National Cheng Kung University Hospital, Tainan City -
10:45am - 12:00pm PT
Factors Influencing Post-Operative Pain in Gynecologic Cancer Patients Receiving High Dose Rate Brachytherapy: An ERAS Risk Factor Analysis
Speaker: Darien Colson-Fearon, MD, MPH - MD Anderson Cancer Center, Houston -
10:45am - 12:00pm PT
First Report of Bulboclitoris Dosimetry and Sexual Toxicity after Gynecologic Cancer Interstitial Brachytherapy
Speaker: Juhi Purswani, MD - Hartford Healthcare, Hartford -
10:45am - 12:00pm PT
-
10:45am - 12:00pm PT
From Guidelines to Real-World Practice: Patterns of Care in Elderly Head and Neck Cancer Patients from a Tertiary Care Center
Speaker: Anjali R, MD, MBBS - All India Institute of Medical Sciences, New Delhi -
10:45am - 12:00pm PT
Functional, Patient-Reported, and Physician-Graded Gustatory Outcomes in Nasopharyngeal Carcinoma Survivors Following IMRT
Speaker: James Chow, MBChB - Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon -
10:45am - 12:00pm PT
Global Cancer System Characteristics and Cervical Cancer Outcomes
Speaker: Edward Dee, MD - Memorial Sloan Kettering Cancer Center, Middletown Township -
10:45am - 12:00pm PT
Head and Neck Cancer Radiotherapy Toxicity Prediction across Intra-Fractional Cone-Beam CTs Using Vision Transformers Networks
Speaker: Gautier Hénique, MS - Polytechnique Montreal/CRCHUM, Montreal -
10:45am - 12:00pm PT
Head and Neck Reirradiation with Stereotactic Ablative Radiotherapy: Predictors of Carotid Blow Out Syndrome
Speaker: Mustafa Cengiz, MD - Hacettepe University Faculty of Medicine, Department of Radiation Oncology, Ankara, Turkey, Ankara -
10:45am - 12:00pm PT
Heterogeneity and Influencing Factors of Cancer-Related Fatigue in Patients with Cervical Cancer Undergoing Brachytherapy: A Cross-Sectional Analysis
Speaker: Panfeng Wang, - Peking University Third Hospital, Beijing -
10:45am - 12:00pm PT
Homologous Recombination Deficiency: Is It Relevant in Locally Advanced Cervical Cancer?
Speaker: Jhoan Sebastian Gonzalez Diaz, MD - MD Anderson Cancer Center, Houston -
10:45am - 12:00pm PT
How Adaptive Radiotherapy Benefits for Cervical Cancer Patients: A Clinical Exploration Based on Daily FBCT
Speaker: Yujun Guo, - Sun Yat-sen University Cancer Center, Guangzhou -
10:45am - 12:00pm PT
Hypoxia Region Dose Escalation in Head and Neck Cancer: Dosimetric Analysis and Acute Toxicity
Speaker: Martin Dolezel, MD, PhD, Prof. - University Hospital Olomouc, Olomouc -
10:45am - 12:00pm PT
Identifying Radiomic Features Associated with Vaginal Stenosis for Future Predictive Modeling in Locally Advanced Cervical Cancer Patients Treated with EBRT and Brachytherapy
Speaker: Raksha Narasimhan, BS - University of Miami Miller School of Medicine, Miami -
10:45am - 12:00pm PT
Impact of Body Composition on OAR Dose in Locally Advanced Cervical Cancer Treated with HDR Intracavitary-Interstitial Applicators
Speaker: Justin Tang, MD, MS - Albert Einstein College of Medicine, New York -
10:45am - 12:00pm PT
Impact of Bolus on Clinical Outcomes in Patients Treated with Radiation Therapy for Vulvar Squamous Cell Carcinoma
Speaker: Joshua Stark, BS - University of Tennessee, -
10:45am - 12:00pm PT
Impact of Post-Treatment Lymphopenia on Clinical Outcomes in Locally Advanced Cervical Cancer
Speaker: Amy Yang, BS - University of Virginia, Charlottesville -
10:45am - 12:00pm PT
Impact of Sarcopenia on Survival and Late Toxicity among Patients with Locally Advanced Cervical Cancer Treated with Definitive Chemoradiotherapy and Brachytherapy
Speaker: Salvador Gutierrez Torres, MD - Instituto Nacional de Cancerologia, Mexico City -
10:45am - 12:00pm PT
Impact of Smoking Status on Circulating Tumor HPV DNA in a Diverse Population with Oropharyngeal Cancer
Speaker: Mohammad Zeeshan Ozair, MD, PhD - Montefiore Medical Center/Albert Einstein College of Medicine, Bronx -
10:45am - 12:00pm PT
-
10:45am - 12:00pm PT
Impacts of Elective Neck Management for Cutaneous Carcinomas with Intraparotid Nodal Metastasis
Speaker: Daniel Leach, MD, MEng - The Ohio State University James Cancer Hospital, Columbus -
10:45am - 12:00pm PT
Implementation and Optimization of a 3D-High Dose Rate Brachytherapy Program in a Comprehensive Cancer Center in Sub-Saharan Africa
Speaker: Jazmyne Tabb, MD - University of California, San Diego -
10:45am - 12:00pm PT
Improving Outcomes in Locally Advanced Cervical Cancer: A Prospective Study of Parametrial Boost with Conformal Radiation Therapy
Speaker: Janmenjoy Mondal, MD, MBA, MBBS - Medical College and Hospital Kolkata, Kolkata -
10:45am - 12:00pm PT
Incidence and Clinical Outcomes of Radiation-Induced Second Malignancies Among Patients Treated for HPV-Associated Oropharyngeal Cancers at a Single Institution
Speaker: Erik Davies, MD - Cleveland Clinic Taussig Cancer Center, Cleveland -
10:45am - 12:00pm PT
Induction Chemotherapy Using Paclitaxel and Carboplatin followed by Altered Fractionated Radiation Therapy in Locally Advanced Head and Neck Carcinoma
Speaker: Abdul Mateen, MS, MBBS - MINAR Cancer Hospital, Multan, Multan -
10:45am - 12:00pm PT
Inferring Intratumoral Hypoxia with Targeted Cell-Free Bisulfite Sequencing among Patients with Head and Neck Squamous Cell Carcinoma
Speaker: Payton Clark, BS - Cleveland Clinic Foundation, Cleveland -
10:45am - 12:00pm PT
Initial Experience Utilizing Universal Interstitial Cylinder in Gynecologic Cancers
Speaker: Ryan Zitter, MD, MSc - University of Chicago, Chicago -
10:45am - 12:00pm PT
Initial Results of a Prospective Study of Quad-Shot Radiotherapy in Combination with Immune Checkpoint Inhibition for Advanced/Recurrent Head and Neck Cancer
Speaker: Ryan Hughes, MD - Wake Forest University School of Medicine, Winston Salem -
10:45am - 12:00pm PT
Institutional Experience with Interstitial and Surface Mold Brachytherapy for Head and Neck Cancers: Efficacy, Toxicity, and Clinical Outcomes
Speaker: Bharti Devnani, MBBS, DNB - All India Institute of Medical Sciences, New Delhi -
10:45am - 12:00pm PT
Integrating Mechanistic and Machine Learning Models to Assess Radiotherapy Fractionation Impact on Head and Neck Cancer Survival
Speaker: Igor Shuryak, MD, PhD - Columbia University, New Milford -
10:45am - 12:00pm PT
Integrating Radiomic Features and Circulating Tumor HPV DNA in Predictive AI Models for Personalized Treatment in HPV-Positive Oropharyngeal Cancer
Speaker: Zubir Rentiya, MD, MSc - Cleveland Clinic Foundation, Cleveland -
10:45am - 12:00pm PT
-
10:45am - 12:00pm PT
Intratumoral Microbiome in Cervical Cancer: Associations with Treatment Response via RNA Sequencing
Speaker: Qin Wen, MBBS - School of Medicine, University of Electronic Science and Technology of China, Chengdu 610054, China, Chengdu -
10:45am - 12:00pm PT
Larger <sup>125</sup> I Radiotherapy Plaque Outcomes for Choroidal Melanoma: A Single Institution Retrospective Study
Speaker: Kimi Chauhan, MD, BS, MTM - Mayo Clinic College of Medicine and Science Rochester, Rochester -
10:45am - 12:00pm PT
Late Toxicity and Survival Outcomes Following Intensity-Modulated Radiation Therapy for Recurrent or Second Primary Squamous Cell Carcinomas of the Head and Neck
Speaker: Vikram Chinnaiyan, BS - University of South Florida Morsani College of Medicine, Tampa -
10:45am - 12:00pm PT
Locally Advanced Oral Cavity Cancer Treated with Definitive Chemoradiation: An Organ Preservation Strategy over Three Decades
Speaker: Michael Gutman, MD - University of Chicago, Chicago -
10:45am - 12:00pm PT
Long Term Outcomes of the First 100 Patients Treated with Vaginal Electronic Brachytherapy in the Management of Endometrial Cancer
Speaker: Samuel Shin, MD - Southern California Permanente Medical Group, Ontario -
10:45am - 12:00pm PT
Long-Term Outcome in Nasopharyngeal Carcinoma Following IMRT with Modified Nodal CTV Cranially Based on the International Guideline: A Single Center Experience
Speaker: Qiaojuan Guo, MD, PhD - Fujian Medical University Oncology Hospital, Fuzhou -
10:45am - 12:00pm PT
Machine-Learning Algorithm for Head and Neck Cancer Nodal Volume Segmentation: Expert vs. Learner Comparison
Speaker: Jeffrey Wang, BS - The George Washington University School of Medicine and Health Sciences, Washington -
10:45am - 12:00pm PT
Management of De-Novo Stage IVB Cervical Cancer with Induction Chemotherapy Followed by Definitive Chemoradiation
Speaker: Cira Mollings Puentes, MD, BS - UT MD Anderson Cancer Center, Houston -
10:45am - 12:00pm PT
Management of Recurrent Vulvar Squamous Carcinoma: Patterns of Disease Control and Survival Post-Radiation
Speaker: Cecilia de Sousa, MD, MPH - Johns Hopkins Medicine, Baltimore -
10:45am - 12:00pm PT
Metabolomics and Machine Learning Identify Novel Serum Biomarkers for Nasopharyngeal Carcinoma Diagnosis
Speaker: Zhaodong Fei, - Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou -
10:45am - 12:00pm PT
MRI-Guided Interstitial Brachytherapy for Vaginal Recurrence of Endometrial Cancer Using 2 vs. 3 or More Fractions
Speaker: Juliet Maina, MD, MBBS - University of Cape Town, Cape Town -
10:45am - 12:00pm PT
Nasopharyngeal Cancer Treated with Proton Beam Radiotherapy: Patterns of Disease Control and Toxicity with Extended Follow-Up
Speaker: Anthony Casper, DO - University of Florida Shands Cancer Center, Gainesville -
10:45am - 12:00pm PT
National Cancer Database Analysis of Uterine Carcinosarcoma: An Updated Series in Locally Advanced Stage Patients
Speaker: Ryan Zitter, MD, MSc - University of Chicago, Chicago -
10:45am - 12:00pm PT
NCDB Analysis of Survival Outcomes for Locoregionally Advanced Laryngeal Cancer Treated with Definitive Chemoradiation vs. Surgery
Speaker: Patricia Pius, MD, BS - University of Oklahoma Health Sciences Center, Oklahoma City -
10:45am - 12:00pm PT
Non-Operative Management of Nasal Cavity Cancers with Definitive Proton Beam Therapy or Intensity Modulated Radiation Therapy for Organ Preservation
Speaker: Nikhil Mankuzhy, MD - Memorial Sloan Kettering Cancer Center, Middletown Township -
10:45am - 12:00pm PT
Oncologic Outcomes and Cost-Effectiveness Analysis of 44Gy/20F EBRT for Locally Advanced Cervical Cancer: Pooled Data from Two Prospective Trials
Speaker: Tissana Prasartseree, MD - Siriraj Hospital Mahidol University, Bangkok -
10:45am - 12:00pm PT
Optic Nerve Dose and Long-Term Visual Outcomes for Uveal Melanoma Patients Treated with Eye Plaque Brachytherapy
Speaker: Jared Pasetsky, MD - New York Presbyterian Hospital Columbia Campus, New York -
10:45am - 12:00pm PT
Optimal Preoperative Radiotherapy Dose for Sinonasal Squamous Cell Carcinoma
Speaker: Qian Liu, MD - Mayo Clinic Rochester, Rochester -
10:45am - 12:00pm PT
Outcome Comparisons and Patterns of Failure in Women with FIGO Stage I-II Uterine Clear Cell Carcinoma after Adjuvant Chemotherapy and Radiation Therapy
Speaker: Yoonsun Jee, MD - Henry Ford Hospital-Henry Ford Cancer Institute, Detroit -
10:45am - 12:00pm PT
Outcome of Partial Laryngeal vs. Whole Laryngeal Radiation for Early Stage T1-2N0 Laryngeal Carcinoma
Speaker: Teeradon Treechairusame, MD - Memorial Sloan Kettering Cancer Center, New York -
10:45am - 12:00pm PT
Outcomes in Patients with Benign Tumors of the Head and Neck Treated with LINAC-Based Stereotactic Body Radiation Therapy
Speaker: Anika Patel, BS - Texas Tech Paul L Foster School of Medicine, El Paso -
10:45am - 12:00pm PT
Outcomes of HPV-Positive Oropharyngeal Cancer in Smokers vs. Non-Smokers
Speaker: Michelle Kwan, BA - Northwestern Feinberg School of Medicine, Chicago -
10:45am - 12:00pm PT
Outcomes of Patients with Gastric-Type Adenocarcinoma of the Uterine Cervix after Definitive or Adjuvant Chemoradiotherapy
Speaker: Harshath Gupta, MD - MD Anderson Cancer Center, Houston -
10:45am - 12:00pm PT
Outcomes of Patients with Sinonasal Tumors Treated with Beam Scanning Proton Therapy
Speaker: Alexey Cherchik, Resident Physician - Paul Scherrer Institute, Villigen -
10:45am - 12:00pm PT
Outcomes of Patients with Unresectable Oral Cavity Cancers Treated with Definitive Concurrent Chemoradiotherapy: A 15-Years Single Institution Experience
Speaker: Rawan Alqahtani, MBBS - King Faisal Specialist Hospital and Research Centre, Riyadh -
10:45am - 12:00pm PT
-
10:45am - 12:00pm PT
Patient-Reported Outcomes from a Phase 1-2 Trial of Concurrent Chemoradiation and BMX-001 for Locally Advanced Head and Neck Cancer
Speaker: Mia Salans, MD, BA, MAS - University of California San Francisco, San Francisco -
10:45am - 12:00pm PT
Patterns of Recurrence and Outcomes in Differentiated Thyroid Carcinoma Patients Treated with External Beam Radiotherapy
Speaker: George Yang, MD - H. Lee Moffitt Cancer Center and Research Institute, Tampa -
10:45am - 12:00pm PT
Patterns of Recurrence and Outcomes in Differentiated Thyroid Carcinoma Patients Treated with External Beam Radiotherapy
Speaker: Shivanshu Kumar, BS - University of South Florida, Tampa -
10:45am - 12:00pm PT
Pencil-Beam Proton Therapy for Large-Size and Unfavorably Located Uveal Melanoma: Safety, Toxicity, and Tumor Response
Speaker: Natalia Martynova, MD - Dr. Berezin Medical Institute, Saint-Petersburg -
10:45am - 12:00pm PT
Percutaneous Endoscopic Gastrostomy Tube Placement in Patients with Oropharyngeal Cancer in Single Institution over Five Years
Speaker: Yingzhi Wu, MSN - Memorial Sloan Kettering Cancer Center, New York -
10:45am - 12:00pm PT
Performance of Node-RADS Scoring System for a Standardized Assessment of Normal-Sized Cervical Lymph Nodes in Nasopharyngeal Carcinoma
Speaker: Ziyi Wu, PhD - Clinical Oncology School of Fujian Medical University, Fuzhou -
10:45am - 12:00pm PT
Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy for Palliative Head and Neck Cancer Treatment (PULS-Pal): Trial in Progress
Speaker: Patrick Courtney, MD, MAS - UCLA David Geffen School of Medicine/UCLA Medical Center, Los Angeles -
10:45am - 12:00pm PT
Postoperative Radiotherapy in Buccal-Alveolar Complex Carcinoma: Mapping Failure Patterns for Improved Target Delineation
Speaker: Akash Bellige, MBBS, DNB - Rajiv Gandhi Cancer Institute and Reserach Centre, New Delhi -
10:45am - 12:00pm PT
Potential Contribution of Specific Oral Bacteria to Radiation-Induced Mucositis in Head and Neck Cancer
Speaker: Atsushi Ue, MD - Shimane University Hospital, izumo -
10:45am - 12:00pm PT
Predictive Modeling of Radiation-Induced Dermatitis in Nasopharyngeal Carcinoma Patients Undergoing TomoTherapy Using Machine Learning with Multimodal Data Integration
Speaker: Jiabiao Hong, MD - Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou -
10:45am - 12:00pm PT
Predictors of Osteoradionecrosis following Post-Operative Intensity-Modulated Radiation Therapy and Proton Therapy for Oral Cavity Cancer
Speaker: Teeradon Treechairusame, MD - Memorial Sloan Kettering Cancer Center, New York -
10:45am - 12:00pm PT
Preliminary Report on Benefit of Radiotherapy in Women with Uterine Carcinosarcoma
Speaker: Ryan Zitter, MD, MSc - University of Chicago, Chicago -
10:45am - 12:00pm PT
Preoperative Radiotherapy with or without Chemotherapy in the Management of Endometrial Cancer, Outcomes of Disease Control and Toxicity
Speaker: Christian Rock, MD - UT Health San Antonio MD Anderson Cancer Center, San Antonio -
10:45am - 12:00pm PT
Prognosis and Failure Patterns of 11q13 Amplified Local Advanced Squamous Cell Carcinoma of the Head and Neck
Speaker: Chang Jiang, MD, RT - Shanghai Jiao Tong University, Shanghai -
10:45am - 12:00pm PT
Prophylactic Extended-Field Irradiation vs. Pelvic Radiotherapy in Postoperative Cervical Cancer Patients with Pelvic Lymph Node-Positive
Speaker: Yanjun Du, MS, RT - Department of Gynecologic Oncology, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China. -
10:45am - 12:00pm PT
Prospective Study on Head and Neck Stereotactic Body Radiotherapy: A Tolerance Analysis
Speaker: Stephan Tran, MD, BS, MBS - Sunnybrook Odette Cancer Centre, Toronto -
10:45am - 12:00pm PT
Radiation Therapy for Head and Neck Paragangliomas: Tumor Regression Trends and Overall Outcomes of Surgical and Radiation Approaches
Speaker: Razan Aljudibi, MBBS - King Fahad Medical City, Riyadh -
10:45am - 12:00pm PT
Radiotherapy for the Management of Bone Metastases in Differentiated Thyroid Cancer
Speaker: Colin Faulkner, MD - University of Toronto, Toronto -
10:45am - 12:00pm PT
Randomized Controlled Trial to Analyze Technical Feasibility of Dosimetric Hippocampal Sparing Radiotherapy in Head and Neck Cancers Involving Base of Skull or with Target Volume in Proximity to Hippocampus: An Interim Analysis
Speaker: Ashutosh Mukherji, MD - Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Varanasi -
10:45am - 12:00pm PT
Reconstruction Complications after Adjuvant Radiotherapy for Patients with Skin Cancer
Speaker: Rachel Sabol, MD, PhD - UCSF, San Francisco -
10:45am - 12:00pm PT
Recurrence Sites of FIGO Stage III Endometrial Cancer after Postoperative Radiotherapy
Speaker: Chunmei Li, BS - Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai -
10:45am - 12:00pm PT
Reevaluating Hypopharyngeal Cancer Staging: The Role of HPV Status in Prognosis
Speaker: Shelly Sharma, MD - Baylor College of Medicine Hospital, Houston -
10:45am - 12:00pm PT
Re-Irradiation with SBRT of Locoregionally Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma
Speaker: Lillian Zhang, BA - USF Health Morsani College of Medicine, Tampa -
10:45am - 12:00pm PT
Relationship between RTOG Criteria of Ototoxicity and Sensorineural Hearing Loss Based on Pure Tone Audiometry in Nasopharyngeal Carcinoma Patients Delivered by Intensity Modulated Radiotherapy
Speaker: Xuejiao Song, - Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University, Xi’an -
10:45am - 12:00pm PT
Research on the Application of Raman Spectroscopy in Predicting the Efficacy of Nasopharyngeal Carcinoma Treatment and Assessing Acute Adverse Reactions to Radiotherapy
Speaker: Peng Zhang, MD - Sichuan Cancer Hospital and Institute, Chengdu -
10:45am - 12:00pm PT
Rethinking Whole Tongue Radiation for Oral Tongue Squamous Cell Carcinoma
Speaker: Alexandra Bennett, MD - Mayo Clinic College of Medicine and Science Rochester, Rochester -
10:45am - 12:00pm PT
Retrospective Replanning of EBRT Regimen for Intended Avoidance of Bulboclitoris and Vaginal Canal for GYN Cancer Patients
Speaker: Allison Jones, MS, BS - Duke University, Durham -
10:45am - 12:00pm PT
Risk-Adapted Ipsilateral Mucosal Radiation Volumes for Head and Neck Carcinoma of Unknown Primary: A Single-Institution Experience and Dosimetric Analysis
Speaker: Houda Bahig, MD, PhD - Centre Hospitalier de l'Universite de Montreal, Montreal -
10:45am - 12:00pm PT
Safety and Efficacy of Local Radiotherapy in De Novo Metastatic Nasopharyngeal Carcinoma with Immunochemotherapy: Systematic Review and Meta-Analysis
Speaker: Li Ma, MD - Shenzhen cancer hospital, Shenzhen -
10:45am - 12:00pm PT
Safety and Efficacy of Postoperative Stereotactic Body Radiotherapy for Newly-Diagnosed or Recurrent Head and Neck Cancer
Speaker: Miriam Lane, MD - University of California Los Angeles, Los Angeles -
10:45am - 12:00pm PT
Salivary Gland Cancer Patterns of Failure after Radiotherapy
Speaker: Jeffrey Shogan, DO - University of Pittsburgh Medical Center, Pittsburgh -
10:45am - 12:00pm PT
Salvage Surgery Followed by IORT for Locoregionally Persistent or Recurrent Head and Neck Cancer
Speaker: Ahmed Elguindy, MD - James Cancer Hospital-Solove Research Institute, Columbus -
10:45am - 12:00pm PT
Severe Sleep-Related Symptoms at Start of Radiotherapy Predict Poorer Survival in Oropharyngeal Cancer: Results from a Longitudinal Symptom Cohort
Speaker: Warren Floyd, MD, PhD, BS - MD Anderson Cancer Center, Houston -
10:45am - 12:00pm PT
-
10:45am - 12:00pm PT
Spare the Carotid, Spoil the Larynx: Assessment of Dosimetric Coverage of IMRT Target Volumes with Conventional 3D-Conformal Radiotherapy for Early Glottic Larynx Carcinoma
Speaker: Nicholas Gallardo, BS - Wake Forest University School of Medicine, Winston-Salem -
10:45am - 12:00pm PT
Spurn the Scorecard: Personalized Dose Constraints for Head and Neck Radiotherapy to Minimize Treatment Toxicity
Speaker: Naomi Goldrich, MD - University of Chicago, Chicago -
10:45am - 12:00pm PT
-
10:45am - 12:00pm PT
Stop LCNP: High Dose Steroid Therapy for Late Radiation-Associated Lower Cranial Neuropathy: An Interim Report of a Phase I Dose Finding Trial and Data Registry
Speaker: Zayne Belal, MD - Hospital of the University of Pennsylvania, Philadelphia -
10:45am - 12:00pm PT
Straight-Leg vs. Frog-Leg Radiotherapy Positioning in Locally Advanced Vulvar Carcinoma: A Prospective Randomized Trial Assessing Acute Toxicity and Lymphedema
Speaker: Abdulla Alzibdeh, MD - King Hussein Cancer Center, Amman -
10:45am - 12:00pm PT
Study of Artificial Intelligence-Assisted 3D Printed Vaginal Templates in 3D Brachytherapy for Cervical Cancer
Speaker: Xiaoyan Wu, - Shenzhen Hospital, Cancer Hospital, Chinese Academy of Medical Sciences, Shenzhen -
10:45am - 12:00pm PT
Survival Outcomes in Patients Receiving Radiation for Locally Advanced Cervical Cancer Based on Facility Type
Speaker: Rebecca Marchant, MD - University of California at San Diego, La Jolla -
10:45am - 12:00pm PT
Tailoring Surgery to Radiotherapy Response in T4b Sinonasal Squamous Cell Carcinoma: A Multicenter Study
Speaker: Qian Liu, MD - Mayo Clinic Rochester, Rochester -
10:45am - 12:00pm PT
-
10:45am - 12:00pm PT
Temporal Trends and Demographic Patterns in Cervical Cancer Mortality in the United States (1999-2020)
Speaker: Perisa Ashar, BS - Duke University, Durham -
10:45am - 12:00pm PT
The Benefit of Repeat Magnetic Resonance Imaging before Each Fraction for Gynecological Brachytherapy
Speaker: Matthew Roozeboom, DO - University of Iowa Health Care, Iowa City -
10:45am - 12:00pm PT
The Dosimetric Feasibility of Lattice Radiotherapy for Cervical Cancer with a Novel X - Ray and ? - Ray Combined Approach
Speaker: Wei Wang, MD - Department of Radiation Oncology, Xijing Hospital, Air Force Medical University, Xi’an -
10:45am - 12:00pm PT
The Efficacy and Safety of Lobaplatin vs. Cisplatin in Concurrent Chemoradiotherapy for Elderly Patients with Cervical Cancer: An Open-Label,Prospective Phase 2 Study
Speaker: Lili Hu, - Department of Gynecologic Oncology, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China. -
10:45am - 12:00pm PT
The Genomic Landscape of Human Papillomavirus Positive Early-Stage Oropharyngeal Carcinoma
Speaker: Matthew Brown, MD - University of Maryland Radiation Oncology, Baltimore -
10:45am - 12:00pm PT
-
10:45am - 12:00pm PT
The Impact of Lymphatic vs. Vascular Invasion on Clinical Outcomes in Early-Stage Endometrial Cancer
Speaker: Niki Tselepidakis, MD - University of Virginia School of Medicine, Charlottesville -
10:45am - 12:00pm PT
The Landscape of Vulvar Cancer: Treatment Characteristics and Survival in Botswana
Speaker: Hafsa Khalil, BS - UT Southwestern Medical Center, Dallas -
10:45am - 12:00pm PT
The Optimal Fractionated Pattern of Adjuvant Radiation for Patients with Adenocarcinoma of Cervix after Radical Surgery: 45Gy/25f vs. 50.4Gy/28f
Speaker: Xilin Yang, MD - Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing -
10:45am - 12:00pm PT
The Role of the Sigmoid Colon in Late Gastrointestinal Toxicity in Cervical Cancer Patients Receiving Definitive Chemoradiation
Speaker: Phoebus Sun Cao, MD - SUNY Upstate Medical University, Syracuse -
10:45am - 12:00pm PT
The Study of a Novel Free-Assembled Interstitial Template Used in Cervical Cancer Brachytherapy
Speaker: Ranxi Liang, - Sichuan Cancer Hospital, Chengdu -
10:45am - 12:00pm PT
The Value of Pre-Brachytherapy MRI in Aiding Applicator Selection for Cervical Cancer Treatment
Speaker: Jennifer Chiang, MD, MS - Stanford Health Care, Palo Alto -
10:45am - 12:00pm PT
Trends in Management of Node Positive Endometrial Cancer after GOG 258 and PORTEC 3
Speaker: Marie Fort, MD - Duke University Hospital, Durham -
10:45am - 12:00pm PT
Trends in Utilization of Locoregional Radiotherapy for De Novo Metastatic Nasopharyngeal Carcinoma
Speaker: Lokesh Seth, MD, MS - Piedmont Macon GA, Roswell -
10:45am - 12:00pm PT
Tumor Control Probability Modeling of Pulmonary Metastases in Oligometastatic Head and Neck Squamous Cell Carcinoma Treated with Stereotactic Body Radiotherapy
Speaker: Alexander Ruhle, MD - Princess Margaret Cancer Center, University Health Network, Toronto -
10:45am - 12:00pm PT
Updates on Prospective Phase III Trial of Standard of Care Therapy with/without Stereotactic Ablative Radiation Therapy for Recurrent Ovarian Cancer
Speaker: Yong Bae Kim, MD - Yonsei Cancer Center, Yonsei University College of Medicine, Seoul -
10:45am - 12:00pm PT
Vaginal Cylinder Brachytherapy: An Analysis of Dose/Fractionation Regimens on Vaginal Stenosis and Endometrial Cancer Local Recurrence
Speaker: Christopher Zazueta, BS - UC Davis School of Medicine, Sacramento -
10:45am - 12:00pm PT
Validation and Development of a Refined M1 Category for Nasopharyngeal Carcinoma Based on the Ninth-Version of AJCC/UICC TNM Staging System in the Immunotherapy Era: A Multicenter Cohort Study
Speaker: Hanchuan Xu, - Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China., Fuzhou, Fujian -
10:45am - 12:00pm PT
Vertebral Artery-Sparing IMPT for Patients with Nasopharyngeal Carcinoma- Dosimetry and Clinical Outcomes.
Speaker: Yu-Ming Wang, MD - Kaohsiung Chang Gung Memorial Hospital, Kaohsiung -
10:45am - 12:00pm PT
What is the Optimal Fractionation for Image-Based High-Dose-Rate Brachytherapy Boost in Medically Inoperable Endometrial Cancer: 4 vs. 5 Fractions?
Speaker: Abigail Groszkiewicz, MD - University of Pittsburgh Medical Center, Pittsburgh -
10:45am - 12:00pm PT
Workflow and Treatment Volumes for UMCC2023.006: A Pilot Phase II Trial of Individualized FDG-PET and DCE-MRI Directed Adaptive RT in HPV-related Stage III Oropharynx Cancer (OPSCC)
Speaker: Batoul Nasser, MD, MS - University of Michigan Hospital, Ann Arbor